Overview
Updated 14 Jul 2026
Mikkael A. Sekeres, MD, is Chief, Division of Hematology, and Professor of Medicine with Tenure, Department of Medicine, University of Miami Miller School of Medicine at Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Department of Medicine, Division of Hematology. The public record shows 1,453 publications with 37,894 citations (h-index 92), centered on Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 22 companies.
- Most recent indexed publication: 2026 · Leukemia
- Top research focus: Acute Myeloid Leukemia Research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 401.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Public positionssourced statements on record
- Served on the FDA Oncologic Drugs Advisory Committee panel involved in the 2012 decision to withdraw accelerated approval of bevacizumab for breast cancer
and publicly commented on the ethical implications
2012provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newswise.com ↗ - Former Chair
FDA Oncologic Drugs Advisory Committee (ODAC); publicly endorsed FDA approval of imetelstat, testifying "I believe the benefits associated with the drug justify the risks..."
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Sponsor: Takeda
InvestigatorPhase 3RecruitingNCT07422480 - A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Sponsor: Takeda
InvestigatorPhase 3RecruitingNCT06499285 - Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
Sponsor: Mikkael Sekeres, MD
InvestigatorPhase 1/PHASE2SuspendedNCT04539236
Industry payments
Updated 14 Jul 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20255 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Takeda Pharmaceuticals U.S.A., Inc.Program year20252 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- Board Certification: Medical Oncology
American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Editorial & leadership rolesjournal and society appointments
- Chief
Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Professor of Medicine with Tenure
University of Miami Miller School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Chair
ASH Treatment Guidelines for Older Adults with Acute Myeloid Leukemia (AML)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
Awards & honorshonors on the public record
- Elected Councillor
American Society of Hematology (ASH) Executive Committee, four-year term beginning after the 2025 ASH Annual Meeting
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eurekalert.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
Secondary affiliationsappointments beyond the home institution
- Former Professor of Medicine
Director of the Leukemia Program, and Vice Chair for Clinical Research, Cleveland Clinic Taussig Cancer Institute
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗ - Physician Liaison in Hematology / co-Chair
Medical Advisory Board, Aplastic Anemia and MDS International Foundation (AAMDSIF), since 2004
2004verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗ - Member
American Society of Clinical Oncology (ASCO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mitpress.mit.edu ↗
- Author of over 100 essays/op-eds in major publications including The New York Times
Wall Street Journal, Washington Post, Slate, and The Hill
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/mikkael-sekeres-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/mikkael-sekeres-93a648231
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
mikkaelsekeres.com/about-me
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mikkaelsekeres.com ↗
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/sylvestercancer/p/C6rVuu7LGjo
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Facebook
m.facebook.com/SylvesterCancer/videos/meet-dr-mikkael-a-sekeres-dr-sekeres-chief-of-hematology-at-sylvester-explains-h/345427397602383
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →m.facebook.com ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/cancer-stories-the-art-of-oncology/id1365887382
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Felipe Medeiros, MD
University of Miami
- 594
- publications
- 85
- h-index
- 4
- trials
Jeffrey Goldberger, MD
University of Miami
- 583
- publications
- 76
- h-index
- 2
- trials
Steven Gedde, MD
University of Miami
- 206
- publications
- 41
- h-index
- 2
- trials